141 related articles for article (PubMed ID: 29705808)
21. Targeted transcriptional upregulation of SENP1 by CRISPR activation enhances deSUMOylation pathways to elicit antinociception in the spinal nerve ligation model of neuropathic pain.
Gomez K; Allen HN; Duran P; Loya-Lopez S; Calderon-Rivera A; Moutal A; Tang C; Nelson TS; Perez-Miller S; Khanna R
Pain; 2024 Apr; 165(4):866-883. PubMed ID: 37862053
[TBL] [Abstract][Full Text] [Related]
22. The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression.
Rodríguez-Castañeda F; Lemma RB; Cuervo I; Bengtsen M; Moen LM; Ledsaak M; Eskeland R; Gabrielsen OS
J Biol Chem; 2018 Oct; 293(40):15439-15454. PubMed ID: 30082317
[TBL] [Abstract][Full Text] [Related]
23. SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1.
Wang JQ; Lin ZC; Li LL; Zhang SF; Li WH; Liu W; Song BL; Luo J
J Biol Chem; 2021; 296():100032. PubMed ID: 33154164
[TBL] [Abstract][Full Text] [Related]
24. SUMO-specific protease 1 regulates the in vitro and in vivo growth of colon cancer cells with the upregulated expression of CDK inhibitors.
Xu Y; Li J; Zuo Y; Deng J; Wang LS; Chen GQ
Cancer Lett; 2011 Oct; 309(1):78-84. PubMed ID: 21669491
[TBL] [Abstract][Full Text] [Related]
25. Antileukemic effects of topoisomerase I inhibitors mediated by de-SUMOylase SENP1.
Niu Q; Hou W; Yan Y; Sun S; Lin Y; Fang H; Ma C; Dong C; Cheng Y; Xu Y; Ding M; Wang S; Cui Z; Chen Y; Li H; Li H; Xiao N
Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166492. PubMed ID: 35850175
[TBL] [Abstract][Full Text] [Related]
26. SUMO-specific protease 2-mediated deSUMOylation is required for NDRG2 stabilization in gastric cancer cells.
Hu XY; Liu Z; Zhang KL; Feng J; Liu XF; Wang LY; Wang ZW
Cancer Biomark; 2017 Dec; 21(1):195-201. PubMed ID: 29060933
[TBL] [Abstract][Full Text] [Related]
27. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
Mirecka A; Morawiec Z; Wozniak K
Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
[TBL] [Abstract][Full Text] [Related]
28. SENP1 induces prostatic intraepithelial neoplasia through multiple mechanisms.
Bawa-Khalfe T; Cheng J; Lin SH; Ittmann MM; Yeh ET
J Biol Chem; 2010 Aug; 285(33):25859-66. PubMed ID: 20551310
[TBL] [Abstract][Full Text] [Related]
29. Important role of SUMOylation of Spliceosome factors in prostate cancer cells.
Wen D; Xu Z; Xia L; Liu X; Tu Y; Lei H; Wang W; Wang T; Song L; Ma C; Xu H; Zhu W; Chen G; Wu Y
J Proteome Res; 2014 Aug; 13(8):3571-82. PubMed ID: 25027693
[TBL] [Abstract][Full Text] [Related]
30. SENP1 Interacts with HIF1α to Regulate Glycolysis of Prostatic Carcinoma Cells.
Wang C; Tao W; Ni S; Chen Q
Int J Biol Sci; 2019; 15(2):395-403. PubMed ID: 30745829
[No Abstract] [Full Text] [Related]
31. SENP1 participates in the dynamic regulation of Elk-1 SUMOylation.
Witty J; Aguilar-Martinez E; Sharrocks AD
Biochem J; 2010 May; 428(2):247-54. PubMed ID: 20337593
[TBL] [Abstract][Full Text] [Related]
32. SENP1 participates in Irinotecan resistance in human colon cancer cells.
Chen MC; Nhan DC; Hsu CH; Wang TF; Li CC; Ho TJ; Mahalakshmi B; Chen MC; Yang LY; Huang CY
J Cell Biochem; 2021 Oct; 122(10):1277-1294. PubMed ID: 34037277
[TBL] [Abstract][Full Text] [Related]
33. SENP1-mediated NEMO de-SUMOylation inhibits intermittent hypoxia induced inflammatory response of microglia in vitro.
Yang T; Sun J; Wei B; Liu S
J Cell Physiol; 2020 Apr; 235(4):3529-3538. PubMed ID: 31549402
[TBL] [Abstract][Full Text] [Related]
34. Akt SUMOylation regulates cell proliferation and tumorigenesis.
Li R; Wei J; Jiang C; Liu D; Deng L; Zhang K; Wang P
Cancer Res; 2013 Sep; 73(18):5742-53. PubMed ID: 23884910
[TBL] [Abstract][Full Text] [Related]
35. Loss of SUMOylation on ATF3 inhibits proliferation of prostate cancer cells by modulating CCND1/2 activity.
Wang CM; Yang WH
Int J Mol Sci; 2013 Apr; 14(4):8367-80. PubMed ID: 23591848
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of SUMO1/Sentrin specific peptidase 1 (SENP1) in prostate cancer is limited to ERG-fusion positive tumors lacking PTEN deletion.
Burdelski C; Menan D; Tsourlakis MC; Kluth M; Hube-Magg C; Melling N; Minner S; Koop C; Graefen M; Heinzer H; Wittmer C; Sauter G; Simon R; Schlomm T; Steurer S; Krech T
BMC Cancer; 2015 Jul; 15():538. PubMed ID: 26202067
[TBL] [Abstract][Full Text] [Related]
37. Tumor-suppressive microRNA-145 induces growth arrest by targeting SENP1 in human prostate cancer cells.
Wang C; Tao W; Ni S; Chen Q; Zhao Z; Ma L; Fu Y; Jiao Z
Cancer Sci; 2015 Apr; 106(4):375-82. PubMed ID: 25645686
[TBL] [Abstract][Full Text] [Related]
38. SUMO-Specific Protease 1 Is Critical for Myeloid-Derived Suppressor Cell Development and Function.
Huang X; Zuo Y; Wang X; Wu X; Tan H; Fan Q; Dong B; Xue W; Chen GQ; Cheng J
Cancer Res; 2019 Aug; 79(15):3891-3902. PubMed ID: 31186231
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of SENP1 inhibits cell proliferation, migration and promotes apoptosis in human glioma cells.
Zhang QS; Zhang M; Huang XJ; Liu XJ; Li WP
Oncol Lett; 2016 Jul; 12(1):217-221. PubMed ID: 27347128
[TBL] [Abstract][Full Text] [Related]
40. SENP1 knockdown-mediated CTCF SUMOylation enhanced its stability and alleviated lipopolysaccharide-evoked inflammatory injury in human lung fibroblasts via regulation of FOXA2 transcription.
Kang L; Wang X; Wang J; Guo J; Zhang W; Lei R
Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130500. PubMed ID: 37914145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
